Nerve Growth Factor Eye Drops Show Four-Year Safety in Children With Optic Pathway Gliomas
A four-year observational follow-up of children treated with nerve growth factor eye drops in a randomized phase II trial shows ...
A four-year observational follow-up of children treated with nerve growth factor eye drops in a randomized phase II trial shows ...
A single-center study of 14 adults found proton radiotherapy delivered durable tumor control, 100 percent five-year survival, and predominantly mild ...
A case report documents the exceptionally rare coexistence of Fahr-type intracranial calcification and a presumed cerebellar pilocytic astrocytoma causing obstructive ...
A first-of-its-kind Swiss national registry study finds that children with low-grade gliomas achieve over 90 percent long-term survival, while revealing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine